Orthofix Medical Inc. a medical device and biologics company in the United States, Italy, Germany, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Extremities.
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential
Orthofix Medical news
06.05.2022
Orthofix Medical's GAAP loss for 3 months of 2022 was $4.46 million, down 23.3% from $5.816 million in the prior year. Revenue increased 0.8% to $106.418 million from $105.593 million a year earlier.
Source: 
ir.orthofix.com
ir.orthofix.com
25.02.2022
Orthofix Medical's GAAP loss for 2021 was $38.379 million, compared to a profit of $2.517 million in the previous year. Revenue increased 14.2% to $464.479 million from $406.562 million a year earlier.
Source: ir.orthofix.com
ir.orthofix.com
05.11.2021
Orthofix Medical reported a GAAP loss of $5.567 million for 9M 2021, against a profit of $11.895 million in the previous year. Revenue increased 17.5% to $339.415 million from $288.943 million a year earlier.
Source: ir.orthofix.com
ir.orthofix.com
06.08.2021
Orthofix Medical' GAAP loss for six months 2021 was $3.396 million, compared to a profit of $7.241 million in the previous year. Revenue increased 27.6% to $226.987 million from $177.958 million a year earlier.
Source: ir.orthofix.com
ir.orthofix.com
General information
| Company name | Orthofix Medical |
|---|---|
| Tags | #medtech |
| Sector | Health Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Equipment |
| Business address | 3451 PLANO PARKWAY LEWISVILLE TX 75056 214-937-2000 |
| Mailing address | 3451 PLANO PARKWAY LEWISVILLE TX 75056 |
| Website | www.orthofix.com |
| Information disclosure | www.sec.gov |
English (US) 